Click here to subscribe to the Multiple Sclerosis News Today Newsletter!
4.4
(47)
Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference.
Reducing the essential amino acid methionine in the diet lessened multiple sclerosis (MS)-like symptoms in a mouse model of the disease, new research shows.
The findings suggest that a methionine-restricted diet, or treatments that target methionine-related biological processes, could be beneficial in MS.
The data were shared in the presentation, “Impact of Methionine Intake on Inflammation,” presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2021 by Catherine Larochelle, MD, PhD, professor at the Université de Montréal in Canada.